发明名称 Compounds useful for multi-level specific targeting of cancer cells
摘要 A compound comprising, in combination: a cell surface binding ligand or internalizing factor, such as an IL-13Rα2 binding ligand; at least one effector molecule (e.g., one, two, three or more effector molecules); optionally but preferably, a cytosol localization element covalently coupled between said binding ligand and said at least one effector molecule; and a subcellular compartment localization signal element covalently coupled between said binding ligand and said at least one effector molecule (and preferably with said cytosol localization element between said binding ligand and said subcellular compartment localization signal element). Methods of using such compounds and formulations containing the same are also described.
申请公布号 US9005600(B2) 申请公布日期 2015.04.14
申请号 US201213718166 申请日期 2012.12.18
申请人 Wake Forest University Health Sciences 发明人 Debinski Waldemar;Pandya Hetal;Gibo Denise
分类号 C07K14/54;A61K38/20;C07K14/21;C07K19/00;C07K14/34;G01N33/50;G01N33/532;G01N33/68;A61K38/00 主分类号 C07K14/54
代理机构 Myers Bigel Sibley & Sajovec, P.A. 代理人 Myers Bigel Sibley & Sajovec, P.A.
主权项 1. A compound comprising, in combination: an IL-13Rα2 binding ligand, wherein said IL-13Rα2 binding ligand is IL-13, a mutant of IL-13, or an IL-13Rα2 binding fragment thereof; at least one effector molecule; a cytosol localization element covalently coupled between said binding ligand and said at least one effector molecule; and a subcellular compartment localization signal element covalently coupled between said binding ligand and said at least one effector molecule, wherein said compound is a fusion protein or a covalent conjugate.
地址 Winston-Salem NC US